Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novavax Inc NVAX

Healthcare Biotechnology
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID... see more

Recent & Breaking News (NDAQ:NVAX)

Important January 11, 2022 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. Investors of Securities Fraud Class Action Lawsuit

Newsfile November 21, 2021

NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders

Newsfile November 20, 2021

NVAX ALERT: Novavax, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PR Newswire November 20, 2021

Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Novavax, Inc. - NVAX

PR Newswire November 19, 2021

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Novavax, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 11, 2022 - (NVAX)

Newsfile November 19, 2021

INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile November 19, 2021

NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders

Newsfile November 19, 2021

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Novavax, Inc. (NVAX)

Business Wire November 19, 2021

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Novavax, Inc. - NVAX

PR Newswire November 18, 2021

NVAX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Novavax, Inc.

Newsfile November 18, 2021

SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Novavax Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf

Business Wire November 18, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, FB and NVAX

Accesswire November 18, 2021

NVAX SECURITIES FRAUD: Hagens Berman, National Trial Attorneys, Encourages Novavax (NVAX) Investors with Significant Losses to Contact Firm's Attorneys Now, Securities Class Action Pending

Newsfile November 18, 2021

LAWSUITS FILED AGAINST CEI, LSPD And NVAX - Jakubowitz Law Pursues Shareholders Claims

Accesswire November 18, 2021

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile November 18, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of Z, SBTX and NVAX

Accesswire November 18, 2021

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire November 18, 2021

NOVAVAX, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Maryland against Novavax, Inc.

PR Newswire November 18, 2021

SHAREHOLDER ALERT: Z LSPD NVAX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire November 18, 2021

NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders

Newsfile November 17, 2021